About Biocon Biocon's Products & Services Research & Development Biocon's Technology Investors Media Careers CSR
Syngene Profile
  > MEDIA
  Overview
  Press Releases
  Media Stories
  Download Center
    Pictures
    Biocon Profile
    Ms. Kiran's Profile
    CSR Policy
    Annual Reports
    Financial Results
  Video Gallery
  Photo Gallery
  Media Contacts
  
  
     
  Download Center  
     
  Syngene Profile  
     
  Click to download Syngene Profile  
 

 

Syngene International

Established in 1994 as a subsidiary of Biocon Limited, Syngene is an internationally reputed custom research and manufacturing company with multi-disciplinary skills in integrated drug discovery and development, with capabilities in medicinal chemistry, biology, in vivo pharmacology, toxicology, custom synthesis, process R&D, cGMP manufacturing and formulation development for both small and large molecules. Syngene has over 1500 scientists and supports R&D programs from lead generation to clinical supplies.

We are currently offering these services to over 70 clients globally. These services are offered on a strong platform of confidentiality and intellectual property protection. Our highly experienced scientific and strong project management teams ensure execution of projects in a timely and cost effective manner with high standards of quality. Our research facilities are certified with ISO 9001:2008, ISO 14001:2004, OHSAS 18001:2007. Our animal facilities are GLP certified by the Indian authorities and also AAALAC accredited.

Syngene has state-of-the-art facilities spread across 90 acres with 1,000,000 sq. ft. of working space. This includes approximately 500,000 sq ft of Chemistry & Biology laboratories, cGMP Kilo Lab, Bio manufacturing Facilities, Animal Facility and Formulation Development Centre. We have over 17 years of experience in successfully offering our services from startup companies to large pharmas in USA, Europe and Asia Pacific including Japan.

Syngene’s customer centre approach focuses on high standards of quality, safety, integrity and corporate governance.

Our operations are guarded by stringent EHS policy and our focus on IP protection makes us a preferred partner for our customers.


 
     
Download Syngene Profile
  Related links:
    People
    Product Glossary
    Financial Highlights
    Photo Gallery
     
  Biocon

Businesses

Recommended sites Biocon on  
  Home
About Us

Investor Relations
Media Relations
Careers
Site Map
Contact Us
Our Growth Accelerators
Fact Sheet
Branded Formulations
Biopharmaceuticals
Research Services
Active Discovery Program

ABLE
Karnataka Vision Group on BT
Syngene International
Biocon Academy

    Linked In   
       
  Report adverse event/side effects and product complaints    
       
  * Disclaimer            © 2016, Biocon. All Rights Reserved